Pharmaceutical

DMTs are major clinical research focus for Parkinson’s disease, analysis shows

GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's disease treatments.

Nov 13, 2024 - 06:00
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's disease treatments.
Read the original article

Tags:

Previous Article

Are dry powder inhalers the key to sustainable respiratory care?

Next Article

Uppsala and KTH Royal develop antibody for potential cancer treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FTC settles with Amgen over $28 billion deal for Horizon

STAT+: FTC settles with Amgen over $28 billion deal for...

Sep 2, 2023

STAT+: Bernie Sanders adds three drug shortage policies to pandemic preparedness bill

STAT+: Bernie Sanders adds three drug shortage policies...

Jul 18, 2023

AZ-3102 by Azafaros for Niemann-Pick Disease Type C: Li...

Dec 4, 2023